Chris is the SESLHD Director of Research, Medical Co-Director of the ESCM program of medicine at the Prince of Wales Hospital and a Conjoint Professor of Medicine at the University of NSW.
He co-chairs the translational research working group for the Randwick Health & Innovation Precinct and is a member of the SESLHD executive. He is a Board Member of the Health Science Alliance.
Chris is a graduate of Sydney University and UNSW, researching the role of vitamin D in bone mineral metabolism as well as newer links between the skeleton and the control of carbohydrate metabolism.
He has led a team that has developed software that uses advanced technologies for clinical decision making natural language processing and a distributed data platform for widespread use and safe and secure access to the asset locked within the medical health record. Inpatient management of diabetes and readmission risk algorithms emphasising remote monitoring and community-based responsiveness to chronic illness using data driven innovations are his most recent research and funding priorities. He has strong links across the precinct including Mental Health, Sydney Children’s Hospital and Royal Hospital for Women and supports numerous research activities investigating risk of readmission, inpatient and community-based diabetes management, gestational diabetes and survivors of childhood cancer.
He continues to practice as a physician and endocrinologist using knowledge-based systems for reporting and integrating Bone Mineral Density and osteoporosis fracture identification in clinical practice and continues to pursue opportunities that will enhance the management of osteoporosis in primary care. A dedicated teacher and mentor to future generations of physicians and endocrinologists Chris has at various times held senior teaching and training positions including the director of physician training. He has established a highly regarded teaching program at the Prince of Wales Hospital and Sydney & Sydney Eye Hospitals, supervising numerous young endocrinologists and researchers in the early part of their careers.
He is an invited speaker at national and international meetings and seminars and has authored over 80 peer reviewed manuscripts and book chapters and held several patents for the tissue specific expression of genes in bone.